Clinical trial NCT05621174 - References

Attention Deficit Disorder With Hyperactivity — The Difference in the Mechanism of Action Between Two Brands of Dexamfetamine in Adults With ADHD

Citation(s)

•   Ahearn EP
  The use of visual analog scales in mood disorders: a critical review. J Psychiatr Res. 1997 Sep-Oct;31(5):569-79. doi: 10.1016/s0022-3956(97)00029-0.
•   Ashinoff BK, Abu-Akel A
  Hyperfocus: the forgotten frontier of attention. Psychol Res. 2021 Feb;85(1):1-19. doi: 10.1007/s00426-019-01245-8. Epub 2019 Sep 20.
•   Dan O, Cohen A, Asraf K, Saveliev I, Haimov I
  The Impact of Sleep Deprivation on Continuous Performance Task Among Young Men With ADHD. J Atten Disord. 2021 Jul;25(9):1284-1294. doi: 10.1177/1087054719897811. Epub 2020 Jan 9.
•   Dolder PC, Strajhar P, Vizeli P, Hammann F, Odermatt A, Liechti ME
  Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects. Front Pharmacol. 2017 Sep 7;8:617. doi: 10.3389/fphar.2017.00617. eCollection 2017.
•   Haertzen CA
  Development of scales based on patterns of drug effects, using the addiction Research Center Inventory (ARCI). Psychol Rep. 1966 Feb;18(1):163-94. doi: 10.2466/pr0.1966.18.1.163. No abstract available.
•   HILL HE, HAERTZEN CA, WOLBACH AB Jr, MINER EJ
  THE ADDICTION RESEARCH CENTER INVENTORY: STANDARDIZATION OF SCALES WHICH EVALUATE SUBJECTIVE EFFECTS OF MORPHINE, AMPHETAMINE, PENTOBARBITAL, ALCOHOL, LSD-25, PYRAHEXYL AND CHLORPROMAZINE. Psychopharmacologia. 1963 May 15;4:167-83. doi: 10.1007/BF02584089. No abstract available.
•   Kang H
  The prevention and handling of the missing data. Korean J Anesthesiol. 2013 May;64(5):402-6. doi: 10.4097/kjae.2013.64.5.402. Epub 2013 May 24.
•   Lader MH, Bond AJ
  Interaction of pharmacological and psychological treatments of anxiety. Br J Psychiatry Suppl. 1998;(34):42-8.
•   Lott DC, Kim SJ, Cook EH, de Wit H
  Serotonin transporter genotype and acute subjective response to amphetamine. Am J Addict. 2006 Sep-Oct;15(5):327-35. doi: 10.1080/10550490600859868.
•   Manzar MD, Salahuddin M, Maru TT, Alghadir A, Anwer S, Bahammam AS, Pandi-Perumal SR
  Validation of the adapted Leeds sleep evaluation questionnaire in Ethiopian university students. Health Qual Life Outcomes. 2018 Mar 13;16(1):49. doi: 10.1186/s12955-018-0876-0.
•   Martin WR, Sloan JW, Sapira JD, Jasinski DR
  Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther. 1971 Mar-Apr;12(2):245-58. doi: 10.1002/cpt1971122part1245. No abstract available.
•   Parrott AC, Hindmarch I
  The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - a review. Psychopharmacology (Berl). 1980;71(2):173-9. doi: 10.1007/BF00434408.
•   Pourhoseingholi MA, Baghestani AR, Vahedi M
  How to control confounding effects by statistical analysis. Gastroenterol Hepatol Bed Bench. 2012 Spring;5(2):79-83.
•   Schmid Y, Hysek CM, Simmler LD, Crockett MJ, Quednow BB, Liechti ME
  Differential effects of MDMA and methylphenidate on social cognition. J Psychopharmacol. 2014 Sep;28(9):847-56. doi: 10.1177/0269881114542454. Epub 2014 Jul 22.
•   Setnik B, Roland CL, Pixton G, Webster L
  Measurement of Drug Liking in Abuse Potential Studies: A Comparison of Unipolar and Bipolar Visual Analog Scales. J Clin Pharmacol. 2017 Feb;57(2):266-274. doi: 10.1002/jcph.801. Epub 2016 Aug 23.
•   Tarrasch R, Laudon M, Zisapel N
  Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients. Hum Psychopharmacol. 2003 Dec;18(8):603-10. doi: 10.1002/hup.534.
•   Wong YN, Wang L, Hartman L, Simcoe D, Chen Y, Laughton W, Eldon R, Markland C, Grebow P
  Comparison of the single-dose pharmacokinetics and tolerability of modafinil and dextroamphetamine administered alone or in combination in healthy male volunteers. J Clin Pharmacol. 1998 Oct;38(10):971-8. doi: 10.1002/j.1552-4604.1998.tb04395.x.

The Difference in Pharmacodynamic and Pharmacokinetic Profiles Between Tentin and Magisterial Dexamfetamine in Adults With Attention Deficit Hyperactivity Disorder, a Double Blinded Randomised Crossover-controlled Trial

Details for clinical trial NCT05621174